NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
Diagnosing Castleman Disease: Key Considerations
Mateo Bustamante
PeerRevolutionizing Breast Cancer Care: The Emerging Role of Liquid Biopsy Technologies
Heather A. Parsons, MD, MPH
PeerJoshua Brandstadter, MD, PhD, MSc
PeerCHOP’s AI Tool CelloType Could Redefine Tumor Analysis
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
Navigating mCRC: A Closer Look at Biomarker Testing
Tailored to Fit: Precision Medicine in Metastatic CRC